Ranbaxy Laboratories Limited

🇨🇷Costa Rica

Country: 🇨🇷Costa Rica

Ownership: -

Established: 1996-08-30

Employees: -

Market Cap: -

Website

Clinical Trials

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: metformin hydrochloride 1000 mg tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 32

Registration Number: NCT00778466

Locations: 🇺🇸
NovumPharmaceutical Research Services, Las Vegas, Nevada, United States

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 32

Registration Number: NCT00778739

Locations: 🇨🇦
Biovail Contract Research,, Toronto, Ontario, Canada

Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Cyclobenzaprine hydrochloride 10 mg tablet

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00778037

Locations: 🇮🇳
Ranbaxy CPU, Gurgaon, Haryana, India

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Benazepril HCl/ Hydrochlorothiazide 20 mg/ 25 mg Tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 42

Registration Number: NCT00778726

Locations: 🇺🇸
aaiPharma, Inc, Chapel Hill, North Carolina, United States

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: amoxicillin-clavulanic acid 600 mg- 42.9 mg/ 5 mL oral suspension

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 48

Registration Number: NCT00778544

Locations: 🇨🇦
Anapharm, Quebec, Canada

Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 33

Registration Number: NCT00778713

Locations: 🇺🇸
Gateway Medical Research Inc, St. Charles, Missouri, United States

Bioequivalence Study of Gabapentin 400 mg Capsules Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Gabapentin 400mg capsules

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 26

Registration Number: NCT00778271

Locations: 🇨🇦
MDS Pharma Services, Saint-Laurent,, Quebec, Canada

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: cefprozil 500mg tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 27

Registration Number: NCT00778778

Locations: 🇨🇦
MDS Pharma Services, Saint-Laurent, Montreal, Quebec, Canada

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: amoxicillin 400mg + clovalunic acid 57.5mg tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00778661

Locations: 🇺🇸
MDS Pharma Services, Phoenix, Arizona, United States

A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Metformin solution 100 mg/mL

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 34

Registration Number: NCT00778349

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy